Awarded contract

Consultancy for clinical and laboratory requirements specification as part of NG-Dx

Details

Supplier(s)
Umio
Duration
1 year
Topic
Research and development services and related consultancy services
Published
22 December 2025

Tender description

A structured programme of qualitative in-depth interviews and observational research underpinned by outcome-driven methodology (ODI) that will identify and prioritise needs that currently limit efficiency, reproducibility and adoption of multi-omics diagnostics. ## Contract award

Timeline

  1. Completed: Award published22 December 2025
    Current notice
  2. Completed: Award date22 December 2025
  3. Next: Contract expiry date31 March 2027in 7 months

About the buyer

Centre for Process Innovation is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

  • 73000000 · Research and development services and related consultancy services

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

34 similar open tenders

See more open tenders related to Consultancy for clinical and laboratory requirements specification as part of NG-Dx.

Explore all open tenders

Related topics

Topics related to Consultancy for clinical and laboratory requirements specification as part of NG-Dx, ranked by notice volume.

View all topics
TopicCountValue
  1. 1,745
    £636.1bn

Win more public sector contracts

Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.